Related Experiment Videos
Biopsy of the red patch at cystoscopy: is it worthwhile?
M J Swinn1, M M Walker, L J Harbin
1Department of Urology, Imperial College London, St Mary's Campus, Norfolk Place, London W2 1PG, UK.
European Urology
|March 26, 2004
Summary
Routine bladder biopsies of red patches are valuable, especially for patients over 60 or with a history of bladder cancer. This practice helps detect malignancy, including carcinoma in situ (CIS), improving patient outcomes.
Area of Science:
- Urology
- Oncology
- Diagnostic Pathology
Background:
- Red patches in the bladder are common during cystoscopy and often biopsied to rule out carcinoma in situ (CIS).
- The visual appearance of these red patches is not specific, potentially leading to unnecessary biopsies.
Purpose of the Study:
- To evaluate the diagnostic yield and clinical utility of routine bladder biopsies of red patches.
- To determine if biopsy of these lesions is warranted in specific patient populations.
Main Methods:
- A retrospective analysis of 193 biopsies from bladder red patches over a 4-year period.
- Histopathological examination of biopsies from patients undergoing cystoscopy for various urological conditions.
Main Results:
- Malignancy was detected in 11.9% of red patch biopsies, with 78.3% of these being CIS.
- No malignancies were found in patients under 60 years of age.
Conclusions:
- Biopsy of bladder red patches is a valuable diagnostic tool, yielding malignancy in approximately 12% of cases.
- The procedure is particularly beneficial for patients over 60 and those with a history of transitional cell carcinoma (TCC).